Drugs With Fewest Side-Effects for Treating Irritable Bowel Syndrome Identified, Study Suggests - ScienceDaily
Cedars-Sinai researchers have determined that two prevalent drug therapies -- rifaximin and lubiprostone -- offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication's April print edition. ... Besides Cedars-Sinai, other centers participating in the research included the School of Medicine at Texas Tech University's Health Sciences Center; the UCLA Department of Medicine; Beth Israel Deaconess Medical Center; and Harvard Medical School. Read the full story >> |
Related Stories
How Does Your Garden Grow?
As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.
Adopt a Growth Mindset for a Better Life
A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.
Drug Use, Family History Can Lead to Heart Disease in Younger Adults
Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.
Recent Stories
Texas Tech Physicians Multispecialty Clinic to Open in South Lubbock
The Texas Tech Physicians Multispecialty Clinic will be home to eight clinical services including cardiology, endocrinology, family medicine, internal medicine, orthopaedics (sports medicine), psychiatry, surgery and urology.
TTUHSC Pioneers New Pathway for Pharmacy Education
The TTUHSC Jerry H. Hodge School of Pharmacy is positioning itself for the future with the announcement of its new Pioneer Pathway, an innovative educational pathway that will leverage hybrid learning strategies.
The Texas Tech University Health Sciences Center Master of Public Health Program Awarded Seven-Year Accreditation
The MPH program at the TTUHSC Julia Jones Matthews School of Population and Public Health has been awarded seven-year accreditation by the Council on Education for Public Health (CEPH) through July 1, 2031.